Search research articles
Contact Us
Filters
Showing results (131-140 of 179) with videos related to
Page
of 18
Sort By:
Cancer Clinical Trials
|
January 1, 1980
Phase II study of 4'-(9-acridinylamino) methanesulfon-m- anisidide (AMSA) in metastatic melanoma
S S Legha, S W Hall, K C Powell, et al.
Journal of the American College of Radiology : JACR
|
June 22, 2026
Supply Chain Vulnerabilities in Breast Imaging: Site- and Network-Level Strategies for a Concentrated Consumable Market
Nita Kommula, Ravinder S Legha, Ray Cody Mayo, et al.
Cancer
|
July 13, 2002
Phase I trial of subcutaneous recombinant human interleukin-2 in patients with metastatic melanoma
Omar Eton, Michael G Rosenblum, Sewa S Legha, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 1, 1997
Phase II trial of tirapazamine combined with cisplatin in chemotherapy of advanced malignant melanoma
A Y Bedikian, S S Legha, O Eton, et al.
Cancer Treatment Reports
|
November 1, 1984
Phase II trial of amsacrine in pancreatic carcinoma: a Southwest Oncology Group study
M Inamasu, N Oishi, T Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 1987
High-dose induction chemotherapy of metastatic breast cancer in protected environment: a prospective randomized study
G N Hortobagyi, A U Buzdar, G P Bodey, et al.
Ethnicity & Health
|
July 4, 2017
Differences in nativity, age and gender may impact health behavior and perspectives among Asian Indians
Sohini Dhar, Beverly Gor, Deborah Banerjee, et al.
Cancer Research
|
May 1, 1979
Prognostic factors in metastatic breast cancer treated with combination chemotherapy
K D Swenerton, S S Legha, T Smith, et al.
Cancer Treatment Reports
|
November 1, 1979
Phase II study of hexamethylmelamine alone and in combination with mitomycin C and vincristine in advanced breast carcinoma
S S Legha, A U Buzdar, G N Hortobagyi, et al.
Annals of Internal Medicine
|
February 1, 1982
Reduction of doxorubicin cardiotoxicity by prolonged continuous intravenous infusion
S S Legha, R S Benjamin, B Mackay, et al.
Page
of 18
Search research articles
Search
Showing results (131-140 of 179) with videos related to
Sort By:
Page
of 18
Cancer Clinical Trials
|
January 1, 1980
Phase II study of 4'-(9-acridinylamino) methanesulfon-m- anisidide (AMSA) in metastatic melanoma
S S Legha, S W Hall, K C Powell, et al.
Journal of the American College of Radiology : JACR
|
June 22, 2026
Supply Chain Vulnerabilities in Breast Imaging: Site- and Network-Level Strategies for a Concentrated Consumable Market
Nita Kommula, Ravinder S Legha, Ray Cody Mayo, et al.
Cancer
|
July 13, 2002
Phase I trial of subcutaneous recombinant human interleukin-2 in patients with metastatic melanoma
Omar Eton, Michael G Rosenblum, Sewa S Legha, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 1, 1997
Phase II trial of tirapazamine combined with cisplatin in chemotherapy of advanced malignant melanoma
A Y Bedikian, S S Legha, O Eton, et al.
Cancer Treatment Reports
|
November 1, 1984
Phase II trial of amsacrine in pancreatic carcinoma: a Southwest Oncology Group study
M Inamasu, N Oishi, T Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 1987
High-dose induction chemotherapy of metastatic breast cancer in protected environment: a prospective randomized study
G N Hortobagyi, A U Buzdar, G P Bodey, et al.
Ethnicity & Health
|
July 4, 2017
Differences in nativity, age and gender may impact health behavior and perspectives among Asian Indians
Sohini Dhar, Beverly Gor, Deborah Banerjee, et al.
Cancer Research
|
May 1, 1979
Prognostic factors in metastatic breast cancer treated with combination chemotherapy
K D Swenerton, S S Legha, T Smith, et al.
Cancer Treatment Reports
|
November 1, 1979
Phase II study of hexamethylmelamine alone and in combination with mitomycin C and vincristine in advanced breast carcinoma
S S Legha, A U Buzdar, G N Hortobagyi, et al.
Annals of Internal Medicine
|
February 1, 1982
Reduction of doxorubicin cardiotoxicity by prolonged continuous intravenous infusion
S S Legha, R S Benjamin, B Mackay, et al.
Page
of 18